Thema: DE000A3ENQ51
Schott Pharma, DE000A3ENQ51
SCHOTT Pharma (DE000A3ENQ51) zeigt einen modernen Architektur-Render einer Pharmaverpackungsanlage bei Dämmerung mit großer Glasfassade - Foto: THN
Schott Pharma stock: BofA lifts rating to Neutral
BofA upgraded Schott Pharma stock to Neutral from Underperform and set a EUR 27 price target. The move reflects its medium-term growth view.
ad-hoc-news.de, 01.11.26 12:35 Uhr
Schott Pharma, DE000A3ENQ51
BofA upgrades Schott Pharma stock to Neutral at EUR 27.00 ...
Third-quarter revenue rose 9.87 percent to EUR 281.76 million. Schott Pharma stock costs EUR 25.25 on October 29, 2026, matching the EUR 25.25 Xetra close.
ad-hoc-news.de, 29.10.26 12:49 Uhr
Schott Pharma, DE000A3ENQ51
Deutsche Bank cuts Schott Pharma stock rating to Hold
Third-quarter revenue hit EUR 281.76 million, up 9.87 percent year over year. Schott Pharma stock costs EUR 25.50 on October 27, 2026, matching Xetra.
ad-hoc-news.de, 27.10.26 12:52 Uhr
Schott Pharma, DE000A3ENQ51
LBBW raises target to EUR 26.50 for Schott Pharma stock
Q3 revenue rose 9.87 percent to EUR 281.76 million. Schott Pharma stock was last at EUR 25.80 on October 23, 2026, near its EUR 26.20 high.
ad-hoc-news.de, 25.10.26 13:16 Uhr
Schott Pharma, DE000A3ENQ51
LBBW raises target for Schott Pharma stock from EUR 22 to ...
Q3 revenue reached EUR 281.80 million, up 8.30 percent year over year. Schott Pharma stock costs EUR 25.75 on October 22, 2026 versus EUR 25.80.
ad-hoc-news.de, 22.10.26 12:54 Uhr
Schott Pharma, DE000A3ENQ51
Deutsche Bank cuts Schott Pharma stock to Hold and raises ...
Q3 revenue reached EUR 281.80 million, up 8.30 percent year over year. Schott Pharma stock costs EUR 25.48 on October 20, 2026 versus EUR 25.50 Xetra close.
ad-hoc-news.de, 20.10.26 12:51 Uhr
Schott Pharma, DE000A3ENQ51
BofA lifts Schott Pharma to Neutral with EUR 27 target for ...
Q3 revenue reached EUR 281.8 million, up 8.3 percent at constant currencies. Schott Pharma stock closed at EUR 24.70 on Xetra on October 16, 2026.
ad-hoc-news.de, 18.10.26 13:20 Uhr
Schott Pharma, DE000A3ENQ51
Deutsche Bank cuts Schott Pharma stock rating raises target ...
Deutsche Bank cut its rating and raised its target to EUR 25.00 on October 9, 2026. Schott Pharma stock costs EUR 24.28 versus EUR 24.50.
ad-hoc-news.de, 15.10.26 13:53 Uhr
Schott Pharma, DE000A3ENQ51
Schott Pharma stock reports 8.3 percent Q3 growth
Schott Pharma stock points to EUR 281.8 million Q3 revenue for the period ended June 30, 2026. The company targets a 27%-28% EBITDA margin for fiscal 2026.
ad-hoc-news.de, 05.10.26 19:20 Uhr
Schott Pharma, DE000A3ENQ51
Schott Pharma stock after-hours at EUR 24.63: plus 0.82 ...
